Santhera’s Licensing Partner, Nxera Pharma, Submits Marketing Authorization Application for AGAMREE® (Vamorolone) in South KoreaBy AdminBitOctober 23, 20260 This is a paid press release. Contact the press release distributor directly with any inquiries.
